Company performance
Add to research
Current Price
as of Jun 13, 2025$165.34
P/E Ratio
N/A
Market Cap
$22.58B
Description
Add to research
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Metrics
Add to research
Overview
- HQAustin, TX
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNTRA
- Price$165.34+0.60%
Trading Information
- Market cap$22.58B
- Float94.69%
- Average Daily Volume (1m)1,198,849
- Average Daily Volume (3m)1,367,164
- EPS-$1.47
Company
- Revenue$1.83B
- Rev growth (1yr)36.46%
- Net income-$66.94M
- Gross margin63.12%
- EBITDA margin-13.94%
- EBITDA-$69.94M
- EV$18.26B
- EV/Revenue9.97
- P/EN/A
- P/S12.17
- P/B18.13
- Debt/Equity15.78
Documents
Add to research
SEC Filings
Earnings Calls